Trevi Therapeutics, Inc. SEC filings TRVI

Trevi Therapeutics, Inc. has 537 filings in SEC EDGAR's recent list, going back to Dec 18, 2012. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Trevi Therapeutics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2026 Jun 3, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEF 14A Proxy statement Apr 21, 2026 Apr 21, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
424B5 Prospectus supplement Apr 17, 2026 —
8-K Current report
Material agreement, Results of operations, Other events
Apr 17, 2026 Apr 16, 2026
424B5 Prospectus supplement Apr 16, 2026 —
PRE 14A Preliminary proxy statement Apr 10, 2026 Apr 10, 2026
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
8-K Current report
Other events
Mar 9, 2026 Mar 9, 2026
8-K Current report
Officer or director change
Dec 5, 2025 Dec 1, 2025
S-3ASR Automatic shelf registration Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K Current report
Officer or director change
Aug 20, 2025 Aug 14, 2025
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2025 Jun 11, 2025
8-K Current report
Material agreement, Other events
Jun 4, 2025 Jun 3, 2025
424B5 Prospectus supplement Jun 4, 2025 —
424B5 Prospectus supplement Jun 2, 2025 —
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 29, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 29, 2025 Apr 29, 2025
S-8 Employee stock plan registration Mar 18, 2025 —
10-K Annual report Mar 18, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 18, 2025 Mar 18, 2025
8-K Current report
Other events
Mar 10, 2025 Mar 10, 2025
8-K Current report
Results of operations, Other events
Jan 8, 2025 Jan 8, 2025
8-K Current report
Material agreement, Other events
Dec 16, 2024 Dec 15, 2024
424B5 Prospectus supplement Dec 16, 2024 —
8-K Current report
Other events
Dec 12, 2024 Dec 12, 2024
8-K Current report
Other events
Dec 3, 2024 Dec 3, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Other events
Oct 21, 2024 Oct 21, 2024
8-K Current report
Other events
Oct 4, 2024 Oct 3, 2024
8-K Current report
Officer or director change
Oct 1, 2024 Sep 27, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 13, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 13, 2024
S-8 Employee stock plan registration Mar 20, 2024 —
10-K Annual report Mar 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 20, 2024 Mar 20, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
EFFECT Filing Aug 15, 2023 —
CORRESP Letter to the SEC Aug 14, 2023 —
S-3/A Filing Aug 11, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
UPLOAD Letter from the SEC Jul 5, 2023 —
S-3 Shelf registration Jun 29, 2023 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 29, 2023 Jun 28, 2023
S-8 Employee stock plan registration May 11, 2023 —
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 Jun 28, 2023
PRE 14A Preliminary proxy statement Apr 14, 2023 Jun 28, 2023
8-K Current report
Bylaw or fiscal year change
Apr 14, 2023 Apr 13, 2023
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 16, 2023 Mar 16, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
424B5 Prospectus supplement Sep 23, 2022 —
8-K Current report
Material agreement, Other events
Sep 23, 2022 Sep 22, 2022
424B5 Prospectus supplement Sep 22, 2022 —
8-K Current report
Other events
Sep 19, 2022 Sep 19, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Other events
Jun 29, 2022 Jun 29, 2022
8-K Current report
Shareholder vote results
Jun 23, 2022 Jun 23, 2022
424B5 Prospectus supplement May 16, 2022 —
8-K Current report
Material agreement
May 16, 2022 May 13, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
EFFECT Filing May 11, 2022 —
CORRESP Letter to the SEC May 9, 2022 —
UPLOAD Letter from the SEC May 6, 2022 —
S-8 Employee stock plan registration May 2, 2022 —
S-3 Shelf registration May 2, 2022 —
DEFA14A Additional proxy material May 2, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 23, 2022
D Filing Apr 18, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 7, 2022 Apr 6, 2022
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 17, 2022 Mar 17, 2022
8-K Current report
Other events
Mar 16, 2022 Mar 16, 2022
8-K Current report
Other events
Feb 24, 2022 Feb 24, 2022
8-K Current report
Other events
Feb 1, 2022 Feb 1, 2022
8-K Current report
Listing notice
Jan 14, 2022 Jan 10, 2022
8-K Current report
Other events
Jan 5, 2022 Jan 5, 2022
EFFECT Filing Nov 16, 2021 —
CORRESP Letter to the SEC Nov 12, 2021 —
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
UPLOAD Letter from the SEC Nov 10, 2021 —
S-3 Shelf registration Nov 5, 2021 —
EFFECT Filing Oct 25, 2021 —
D Filing Oct 21, 2021 —
CORRESP Letter to the SEC Oct 21, 2021 —
UPLOAD Letter from the SEC Oct 21, 2021 —
D Filing Oct 20, 2021 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 19, 2021 Oct 15, 2021
S-3 Shelf registration Oct 15, 2021 —
RW Filing Oct 8, 2021 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 1, 2021 Sep 30, 2021
S-1 Registration statement Aug 27, 2021 —
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Shareholder vote results
Aug 9, 2021 Aug 9, 2021
EFFECT Filing Jul 14, 2021 —
424B3 Prospectus Jul 14, 2021 —
CORRESP Letter to the SEC Jul 12, 2021 —
UPLOAD Letter from the SEC Jul 9, 2021 —
8-K Current report
Other events
Jul 9, 2021 Jul 9, 2021
S-1 Registration statement Jul 7, 2021 —
S-8 Employee stock plan registration Jul 7, 2021 —
8-K Current report
Material agreement
Jul 7, 2021 Jul 6, 2021
8-K Current report
Shareholder vote results
Jun 21, 2021 Jun 16, 2021
8-K Current report
Material agreement, Unregistered share sale
Jun 21, 2021 Jun 18, 2021
10-Q Quarterly report May 13, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 13, 2021 May 13, 2021
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 16, 2021
8-K Current report
Officer or director change
Apr 2, 2021 Mar 29, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 25, 2021 Mar 25, 2021
8-K Current report
Officer or director change
Mar 22, 2021 Mar 18, 2021
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 12, 2020 Nov 11, 2020
8-K Current report
Other events
Oct 21, 2020 Oct 21, 2020
8-K Current report
Officer or director change
Sep 11, 2020 Sep 8, 2020
10-Q Quarterly report Aug 13, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 13, 2020 Aug 13, 2020
8-K Current report
Other events
Jul 13, 2020 Jul 13, 2020
EFFECT Filing Jul 2, 2020 —
424B3 Prospectus Jul 2, 2020 —
UPLOAD Letter from the SEC Jun 30, 2020 —
8-K Current report
Officer or director change
Jun 30, 2020 Jun 29, 2020
CORRESP Letter to the SEC Jun 30, 2020 —
S-3 Shelf registration Jun 26, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2020 Jun 11, 2020
DEFA14A Additional proxy material May 29, 2020 —
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 11, 2020
S-8 Employee stock plan registration Mar 16, 2020 —
10-K Annual report Mar 16, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 16, 2020 Mar 16, 2020
8-K Current report
Officer or director change
Feb 18, 2020 Feb 13, 2020
8-K Current report
Officer or director change
Jan 6, 2020 Dec 31, 2019
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 14, 2019 Nov 14, 2019
8-K Current report
Officer or director change
Sep 24, 2019 Sep 18, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 12, 2019 Aug 12, 2019
8-K Current report
Officer or director change
Jul 2, 2019 Jun 28, 2019
10-Q Quarterly report Jun 14, 2019 Mar 31, 2019
8-K Current report
Results of operations
Jun 14, 2019 Jun 13, 2019
8-K Current report
Bylaw or fiscal year change
May 9, 2019 May 9, 2019
424B4 Prospectus May 8, 2019 —
EFFECT Filing May 7, 2019 —
S-8 Employee stock plan registration May 7, 2019 —
FWP Free writing prospectus May 7, 2019 —
UPLOAD Letter from the SEC May 7, 2019 —
CORRESP Letter to the SEC May 7, 2019 —
S-1/A Amended registration statement May 7, 2019 —
S-1/A Amended registration statement May 6, 2019 —
CERT Filing Apr 30, 2019 —
CORRESP Letter to the SEC Apr 29, 2019 —
CORRESP Letter to the SEC Apr 29, 2019 —
8-A12B Filing Apr 29, 2019 —
S-1/A Amended registration statement Apr 22, 2019 —
CORRESP Letter to the SEC Apr 11, 2019 —
S-1 Registration statement Apr 5, 2019 —
DRS/A Filing Feb 21, 2019 —
DRSLTR Filing Feb 20, 2019 —
UPLOAD Letter from the SEC Feb 15, 2019 —
DRSLTR Filing Dec 21, 2018 —
DRS/A Filing Dec 21, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TRVI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1563880

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.